Foresite Capital Management IV as of Dec. 31, 2019
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 14 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 15.7 | $36M | 1.5M | 24.17 | |
| Medicines Company | 14.8 | $34M | 403k | 84.94 | |
| Insmed (INSM) | 14.7 | $34M | 1.4M | 23.88 | |
| Cytokinetics (CYTK) | 11.0 | $26M | 2.4M | 10.61 | |
| Fulcrum Therapeutics (FULC) | 10.8 | $25M | 1.5M | 16.64 | |
| Myokardia | 8.2 | $19M | 260k | 72.88 | |
| Voyager Therapeutics (VYGR) | 5.0 | $12M | 831k | 13.95 | |
| Arbutus Biopharma (ABUS) | 4.4 | $10M | 3.7M | 2.78 | |
| Ascendis Pharma A S (ASND) | 4.1 | $9.6M | 69k | 139.13 | |
| Optinose (OPTN) | 3.5 | $8.0M | 871k | 9.22 | |
| Si-bone (SIBN) | 2.9 | $6.6M | 308k | 21.50 | |
| Alector (ALEC) | 2.6 | $6.1M | 354k | 17.23 | |
| Cymabay Therapeutics | 2.0 | $4.5M | 2.3M | 1.96 | |
| Kura Oncology (KURA) | 0.4 | $935k | 68k | 13.75 |
